Literature DB >> 28895075

Milestones of Parkinson's Disease Research: 200 Years of History and Beyond.

Song Li1,2, Weidong Le3,4,5.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28895075      PMCID: PMC5636740          DOI: 10.1007/s12264-017-0178-2

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  32 in total

1.  Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials.

Authors:  E O Backlund; P O Granberg; B Hamberger; E Knutsson; A Mårtensson; G Sedvall; A Seiger; L Olson
Journal:  J Neurosurg       Date:  1985-02       Impact factor: 5.115

Review 2.  Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.

Authors:  Jing L Guo; Virginia M Y Lee
Journal:  Nat Med       Date:  2014-02       Impact factor: 53.440

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Bromocriptine in Parkinsonism.

Authors:  D B Calne; P F Teychenne; L E Claveria; R Eastman; J K Greenacre; A Petrie
Journal:  Br Med J       Date:  1974-11-23

5.  Galen on tremor, palpitation, spasm, and rigor.

Authors:  D Sider; M McVaugh
Journal:  Trans Stud Coll Physicians Phila       Date:  1979-09

6.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

Authors:  A L Benabid; P Pollak; A Louveau; S Henry; J de Rougemont
Journal:  Appl Neurophysiol       Date:  1987

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

Authors:  R Kumar; A M Lozano; Y J Kim; W D Hutchison; E Sime; E Halket; A E Lang
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

9.  Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

Authors:  J G Nutt; K J Burchiel; C L Comella; J Jankovic; A E Lang; E R Laws; A M Lozano; R D Penn; R K Simpson; M Stacy; G F Wooten
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

10.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors:  Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal:  Nat Genet       Date:  2014-07-27       Impact factor: 38.330

View more
  8 in total

1.  Iron, Dopamine, and α-Synuclein Interactions in at-Risk Dopaminergic Neurons in Parkinson's Disease.

Authors:  Ning Song; Junxia Xie
Journal:  Neurosci Bull       Date:  2018-01-29       Impact factor: 5.203

Review 2.  Biomarkers for Parkinson's Disease: How Good Are They?

Authors:  Tianbai Li; Weidong Le
Journal:  Neurosci Bull       Date:  2019-10-23       Impact factor: 5.203

3.  Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.

Authors:  Yasuhide Mitsumoto; Atsushi Mori
Journal:  Neurosci Bull       Date:  2018-07-09       Impact factor: 5.203

4.  Targeting PTB as a One-Step Procedure for In Situ Astrocyte-to-Dopamine Neuron Reprogramming in Parkinson's Disease.

Authors:  Yuanyuan Jiang; Yongjie Wang; Zhihui Huang
Journal:  Neurosci Bull       Date:  2021-01-13       Impact factor: 5.203

Review 5.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

Review 6.  Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency.

Authors:  Emilia M Gatto; Gustavo Da Prat; Jose Luis Etcheverry; Guillermo Drelichman; Martin Cesarini
Journal:  Brain Sci       Date:  2019-02-01

7.  Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.

Authors:  Masaru Tanaka; József Toldi; László Vécsei
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

8.  Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson's disease.

Authors:  Tianbai Li; Daqing Kou; Yanhua Cui; Weidong Le
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.